BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 30166610)

  • 1. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
    Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
    Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dual-Active Histamine H
    Eissa N; Azimullah S; Jayaprakash P; Jayaraj RL; Reiner D; Ojha SK; Beiram R; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid.
    Baronio D; Castro K; Gonchoroski T; de Melo GM; Nunes GD; Bambini-Junior V; Gottfried C; Riesgo R
    PLoS One; 2015; 10(1):e0116363. PubMed ID: 25560049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist.
    Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Shekari MA
    Behav Pharmacol; 2023 Jun; 34(4):179-196. PubMed ID: 37171458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Multi-Targeting Ligand ST-2223 with Histamine H
    Eissa N; Venkatachalam K; Jayaprakash P; Falkenstein M; Dubiel M; Frank A; Reiner-Link D; Stark H; Sadek B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice.
    Eissa N; Azimullah S; Jayaprakash P; Jayaraj RL; Reiner D; Ojha SK; Beiram R; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Chem Biol Interact; 2019 Oct; 312():108775. PubMed ID: 31369746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous Blockade of Histamine H
    Eissa N; Jayaprakash P; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32872194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats.
    Sadek B; Saad A; Subramanian D; Shafiullah M; Łażewska D; Kieć-Kononowiczc K
    Neuropharmacology; 2016 Jul; 106():46-55. PubMed ID: 26525191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism.
    Kim JW; Seung H; Kwon KJ; Ko MJ; Lee EJ; Oh HA; Choi CS; Kim KC; Gonzales EL; You JS; Choi DH; Lee J; Han SH; Yang SM; Cheong JH; Shin CY; Bahn GH
    PLoS One; 2014; 9(8):e104927. PubMed ID: 25133713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in mice.
    Bahi A; Sadek B; Nurulain SM; Łażewska D; Kieć-Kononowicz K
    Physiol Behav; 2015 Nov; 151():189-97. PubMed ID: 26169446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H3 receptor antagonist, ciproxifan, alleviates cognition and synaptic plasticity alterations in a valproic acid-induced animal model of autism.
    Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Ur Rehman N; Maneshian M
    Psychopharmacology (Berl); 2022 Aug; 239(8):2673-2693. PubMed ID: 35538250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism.
    Mehta MV; Gandal MJ; Siegel SJ
    PLoS One; 2011; 6(10):e26077. PubMed ID: 22016815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid.
    Castro K; Baronio D; Perry IS; Riesgo RDS; Gottfried C
    Nutr Neurosci; 2017 Jul; 20(6):343-350. PubMed ID: 26856821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice.
    Molenhuis RT; Hutten L; Kas MJH
    Pharmacol Biochem Behav; 2022 Jan; 212():173304. PubMed ID: 34856309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
    Mirza R; Sharma B
    Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
    Matsuo K; Yabuki Y; Fukunaga K
    Neuropharmacology; 2020 May; 168():107975. PubMed ID: 31991146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.
    Schneider T; Przewłocki R
    Neuropsychopharmacology; 2005 Jan; 30(1):80-9. PubMed ID: 15238991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats.
    Kumar H; Sharma B
    Brain Res Bull; 2016 Jun; 124():27-39. PubMed ID: 27034117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism.
    Schneider T; Turczak J; Przewłocki R
    Neuropsychopharmacology; 2006 Jan; 31(1):36-46. PubMed ID: 15920505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.